AC
Adam Crystal (President, R&D) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Tango Therapeutics, Inc. (TNGX). The largest single filing was $962K of TNGX (38,460 sh × $25.00, as filed), executed Apr 15. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
12
0 buys · 12 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.9M
shares × price, as filed
Last traded
Oct 1
Filed Oct 5
Median ADV $98.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Sector per market data · by filing · past 12 months
Most traded names
TNGXRecent filings
TNGXSALE
Tango Therapeutics, Inc.
View filing →
$241K12,000 sh × $20.11
Exec Mar 25
Filed Mar 27 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $304K
20,251 sh × $15.00
Exec Mar 5
Filed Mar 9 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $694K
54,345 sh × $12.77
Exec Feb 25
Filed Feb 27 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $224K
18,251 sh × $12.26
Exec Feb 3
Filed Feb 4 · 5:30 PM ET